Ovesco Endoscopy AG
7
1
1
1
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 50/100
14.3%
1 terminated/withdrawn out of 7 trials
50.0%
-36.5% vs industry average
0%
0 trials in Phase 3/4
100%
1 of 1 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (7)
Clinical Evaluation of a New Platform for Bi-manual Endoscopic Resection in the Rectum and Sigma (EndoTEM)
Role: collaborator
Gastroduodenal Full Thickness Resection Device Registry - gdFTRD® Registry
Role: lead
Submucosal Tumor Removal by Endoscopic Excision Therapy
Role: collaborator
Impact of Hybrid-ESD+ and LiftUp® on the en Bloc/R0 Rate in Colorectal Adenomas Between 2 and 3 cm
Role: collaborator
The Use of Novel Over-The-Scope-Clip to Prevent Esophageal Stent Migration
Role: collaborator
Detection of Upper Gastrointestinal (GI) Bleeding With a Novel Bleeding Sensor Capsule [DING]
Role: lead
Endoscopic Full Thickness Resection in the Lower GI Tract With the "Full Thickness Resection Device"
Role: collaborator
All 7 trials loaded